World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
42717
World Ranking
9146
National Ranking
4718

Overview

Brad H. Rovin is affiliated with The Ohio State University in the United States and conducts research primarily within the field of Medicine, with a significant focus on Nephrology. Their work spans multiple specialized subfields including Rheumatology, Immunology, Hematology, and Genetics.

Their research topics concentrate heavily on renal and immune-related diseases. Key research areas include:

  • Renal Diseases and Glomerulopathies
  • Systemic Lupus Erythematosus Research
  • Chronic Kidney Disease and Diabetes
  • Platelet Disorders and Treatments
  • Liver Diseases and Immunity
  • Complement system in diseases
  • Vasculitis and related conditions

Brad H. Rovin has contributed substantially to peer-reviewed literature, with frequent publications in respected journals such as:

  • Kidney International
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Nephrology Dialysis Transplantation
  • Annals of the Rheumatic Diseases

Recent significant papers authored or co-authored by Brad H. Rovin include:

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases (2021) in Kidney International
  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis (2020) in New England Journal of Medicine
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases (2021) in Kidney International
  • An atlas of healthy and injured cell states and niches in the human kidney (2023) in Nature
  • Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2021) in The Lancet

Collaboration is a notable aspect of their scientific activity. Frequent co-authors include:

  • Jonathan Barratt
  • Jai Radhakrishnan
  • Pierre Ronco
  • Jürgen Floege
  • Ana Malvar

The research contributions of Brad H. Rovin explore clinical and translational nephrology topics, with a special emphasis on glomerular diseases and autoimmune conditions affecting the kidney. Their work also intersects with broader immunological and hematological mechanisms relevant to chronic kidney disease and systemic inflammatory disorders.

Best Publications

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

    Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney

  • The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

    Enrique Gonzalez;Hemant Kulkarni;Hector Bolivar;Andrea Mangano

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Update on Lupus Nephritis

    Salem Almaani;Alexa Meara;Brad H. Rovin

  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

    Richard Furie;Brad H. Rovin;Frederic Houssiau;Ana Malvar

  • A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.

    Brad H. Rovin;Ling Lu;Ramesh Saxena

  • Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans

    Yan Yang;Erwin K. Chung;Yee Ling Wu;Stephanie L. Savelli

  • Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression.

    Xi-Lin Chen;Geraldine Dodd;Suzanne Thomas;Xiaolan Zhang

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

    John C. Byrd;Thomas S. Lin;James T. Dalton;Di Wu

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

    Doua Azzouz;Aidana Omarbekova;Adriana Heguy;Dominik Schwudke

  • HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

    Enrique Gonzalez;Brad H. Rovin;Luisa Sen;Glen Cooke

  • Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

    Brad H Rovin;Y K Onno Teng;Ellen M Ginzler;Cristina Arriens

  • Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate

    Sergey V. Brodsky;Tibor Nadasdy;Brad H. Rovin;Anjali A. Satoskar

  • Update on Lupus Nephritis: Core Curriculum 2020.

    Samir V. Parikh;Salem Almaani;Sergey Brodsky;Brad H. Rovin

  • Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus Activity

    Brad H. Rovin;Huijuan Song;Dan J. Birmingham;Lee A. Hebert

  • Uric acid and cardiovascular risk.

    Lee A Hebert;Brad Rovin

Frequent Co-Authors

Jürgen Floege
Jürgen Floege RWTH Aachen University
Jon B. Klein
Jon B. Klein University of Louisville
David S. Pisetsky
David S. Pisetsky Duke University
Ellen M. Ginzler
Ellen M. Ginzler SUNY Downstate Medical Center
Kenneth C. Kalunian
Kenneth C. Kalunian University of California, San Diego
Cynthia Aranow
Cynthia Aranow Feinstein Institute for Medical Research
Betty P. Tsao
Betty P. Tsao University of California, Los Angeles
Hans-Joachim Anders
Hans-Joachim Anders Ludwig-Maximilians-Universität München
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those passionate about healthcare but seeking alternative educational pathways, a variety of online degrees offer flexible options to launch or advance a career in medicine and related fields. These online programs can often be more accessible, allowing you to balance studies with work or family commitments.

Aspiring advanced practice nurses might consider the easiest dnp program online to quickly gain credentials for leadership, clinical, or academic positions. If you're interested in becoming a nurse more rapidly, online lpn programs offer a streamlined route to licensure and practical experience.

Mental health is a growing field, and earning your credentials through online psych np programs can open doors to high-demand roles in psychiatric care. Meanwhile, for those interested in the business and administration side of healthcare, the online master of health administration prepares graduates for leadership opportunities in hospitals, clinics, and health organizations.

Each of these online pathways can pave the way to rewarding careers in healthcare without the need for a traditional, on-campus medical degree.

Best Scientists Citing Brad H. Rovin

Trending Scientists